Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00513591 · ClinicalTrials.gov registry record
Duke Autoimmunity in Pregnancy Registry
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 513
- Enrollment target
NCT00513591: Completed study, sponsored by Duke University.
NCT00513591 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 513 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00513591 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 513 participants
- Enrollment target
Study Summary
It is difficult to predict how a women with an autoimmune disease will do during pregnancy. Some women will improve, others will worsen. Some pregnancies progress normally and others become very complicated. The Duke Autoimmunity in Pregnancy (DAP) Registry will enroll women with autoimmune diseases, such as lupus, rheumatoid arthritis, scleroderma, and Sjogren's syndrome who wish to become, or already are, pregnant. We will follow these women throughout pregnancy to better understand how their autoimmune disease affects their pregnancy, and vice versa.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 513 participants |
| Start Date | 2007-08 |
| Est. Completion | 2018-11-19 |
What the finished NCT00513591 record still lists
NCT00513591 is an observational study that tracks outcomes without assigning an intervention. The registered 513 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00513591 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00513591 about?
NCT00513591 is a clinical study titled "Duke Autoimmunity in Pregnancy Registry". It is difficult to predict how a women with an autoimmune disease will do during pregnancy. Some women will improve, others will worsen. Some pregnancies progress normally and others become very complicated. The Duke Autoimmunity in Pregnancy (DAP) Registry will enroll women with autoimmune disease...
What is the current status of trial NCT00513591?
This trial is currently completed. The enrollment target is 513 participants. The study started on 2007-08. Estimated completion is 2018-11-19.
Who is sponsoring clinical trial NCT00513591?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05691244 · 514 participants · Phase 3
Assess the Safety and Efficacy of Sovateltide in Patients With Acute Cerebral Ischemic Stroke
- NCT06585488 · 514 participants · Phase 1
A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification
- NCT06716606 · 514 participants · Phase 3
A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- NCT05005403 · 512 participants · Phase 1
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of Azirkitug (ABBV-514) Alone or in Combination With Budigalimab or Bevacizumab
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia